SILO PHARMA, INC. Shares Issued
SILO PHARMA, INC. (SILO) had Shares Issued of 1.13 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares, Issued 1.13M shares.
- 2026-03-31: Common Stock, Shares, Issued 16.27M shares.
- 2025-12-31: Common Stock, Shares, Issued 887.89K shares; Common Stock, Shares, Issued as first filed 13.32M shares.
- 2025-09-30: Common Stock, Shares, Issued 10.46M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 1.13M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 16.27M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 887.89K shares 10-Q · filed 2026-08-13 | 13.32M shares 10-K · filed 2026-03-27 |
| 2025-09-30 | 10.46M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 8.65M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 4.48M shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 4.48M shares POS AM · filed 2026-04-14 | |
| 2024-09-30 | 4.49M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 4.08M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 3.16M shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 3.16M shares 10-K · filed 2025-03-28 | |
| 2023-09-30 | 3.11M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 3.11M shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 3.16M shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 3.16M shares 10-K · filed 2024-03-25 | |
| 2022-09-30 | 3.14M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 99.40M shares 10-Q · filed 2022-08-01 | |
| 2022-03-31 | 99.40M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 1.97M shares 10-K · filed 2023-03-24 | 98.64M shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 98.64M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 98.64M shares 10-Q · filed 2021-08-13 | |
| 2021-03-31 | 85.14M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 85.14M shares 10-K · filed 2022-03-28 | |
| 2020-09-30 | 85.14M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 83.14M shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 23.60M shares 10-Q · filed 2020-05-12 | |
| 2019-12-31 | 23.60M shares 10-K/A · filed 2021-05-17 | |
| 2019-09-30 | 23.49M shares 10-Q · filed 2019-11-13 | |
| 2019-06-30 | 23.47M shares 10-Q · filed 2019-08-13 | |
| 2019-03-31 | 23.44M shares 10-Q · filed 2019-05-14 | |
| 2018-12-31 | 23.42M shares 10-K · filed 2020-03-20 | |
| 2018-12-04 | 70.00K shares 10-K · filed 2020-03-20 | |
| 2018-09-30 | 50.08M shares 10-Q · filed 2018-11-14 | |
| 2018-09-29 | 2.00M shares 10-K · filed 2020-03-20 | |
| 2017-12-31 | 50.08M shares 10-K · filed 2019-04-04 | |
| 2013-12-31 | 40.61M shares 10-K · filed 2014-03-31 | |
| 2013-09-30 | 36.23M shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 30.73M shares 10-Q · filed 2013-08-08 | |
| 2013-03-31 | 30.73M shares 10-Q · filed 2013-05-15 | |
| 2012-12-31 | 30.63M shares 10-K · filed 2014-03-31 | |
| 2012-09-30 | 30.63M shares 10-Q · filed 2012-11-13 | |
| 2012-06-30 | 30.63M shares 10-Q · filed 2012-08-01 | |
| 2012-03-31 | 30.63M shares 10-Q · filed 2012-05-15 | |
| 2011-12-31 | 30.63M shares 10-K · filed 2013-03-05 | |
| 2011-09-30 | 30.63M shares 10-Q · filed 2011-11-10 | |
| 2011-06-30 | 30.63M shares 10-Q · filed 2011-08-15 | |
| 2010-12-31 | 30.63M shares 10-K · filed 2012-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |